Therapeutic Advances in Cardiovascular Disease Q2 Unclaimed
Therapeutic Advances in Cardiovascular Disease is a journal indexed in SJR in Cardiology and Cardiovascular Medicine and Pharmacology (medical) with an H index of 41. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on cardiology, vascular medicine, circulatory disorders, cardiac conditions. It has an SJR impact factor of 0,553 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,553.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1350 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,553
SJR Impact factor41
H Index17
Total Docs (Last Year)40
Total Docs (3 years)1230
Total Refs95
Total Cites (3 years)37
Citable Docs (3 years)2.48
Cites/Doc (2 years)72.35
Ref/DocOther journals with similar parameters
Hypertension Research Q2
Frontiers in Cardiovascular Medicine Q2
Interventional Cardiology Review Q2
Interventional Cardiology (London) Q2
European Cardiology Review Q2
Compare this journals
Aims and Scope
Best articles by citations
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
6-minute walking test: a useful tool in the management of heart failure patients
Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
Challenges in management of left ventricular thrombus
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia
Review: Role of the augmentation index in hypertension
Original Research: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
Review: Systemic and uteroplacental renin—angiotensin system in normal and pre-eclamptic pregnancies
Review: Stroke prevention: modifying risk factors
The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease
Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways
Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Pathophysiology, diagnosis, and management of aortic dissection
Left ventricular noncompaction cardiomyopathy: updated review
Burden of comorbidities among patients with atrial fibrillation
Review: The role of the L-arginine-nitric oxide pathway in preeclampsia
Nanomedicine applied to cardiovascular diseases: latest developments
Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events
Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population
Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications
Comments